{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,15]],"date-time":"2026-09-15T21:05:36Z","timestamp":1789506336616,"version":"build-2803163510"},"reference-count":163,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2020,5,25]],"date-time":"2020-05-25T00:00:00Z","timestamp":1590364800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Microbiol."],"DOI":"10.3389\/fmicb.2020.01063","type":"journal-article","created":{"date-parts":[[2020,5,25]],"date-time":"2020-05-25T00:49:06Z","timestamp":1590367746000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":32,"title":["Protein- and Peptide-Based Virus Inactivators: Inactivating Viruses Before Their Entry Into Cells"],"prefix":"10.3389","volume":"11","author":[{"given":"Xiaojie","family":"Su","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qian","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yumei","family":"Wen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shibo","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lu","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2020,5,25]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"987","DOI":"10.1128\/AAC.00793-08","article-title":"Multiple peptides homologous to herpes simplex virus type 1 glycoprotein B inhibit viral infection.","volume":"53","author":"Akkarawongsa","year":"2009","journal-title":"Antimicrob. Agents Chemother."},{"key":"B2","doi-asserted-by":"publisher","first-page":"719","DOI":"10.7150\/ijms.5037","article-title":"Inhibition of dengue virus entry into target cells using synthetic antiviral peptides.","volume":"10","author":"Alhoot","year":"2013","journal-title":"Int. J. Med. Sci."},{"key":"B3","doi-asserted-by":"publisher","first-page":"533","DOI":"10.1089\/aid.1995.11.533","article-title":"Expression and characterization of CD4-IgG2, a novel heterotetramer that neutralizes primary HIV type 1 isolates.","volume":"11","author":"Allaway","year":"1995","journal-title":"AIDS Res. Hum. Retroviruses"},{"key":"B4","doi-asserted-by":"publisher","first-page":"3843","DOI":"10.1021\/acs.jmedchem.5b00073","article-title":"Peptide triazole inactivators of HIV-1 utilize a conserved two-cavity binding site at the junction of the inner and outer domains of Env gp120.","volume":"58","author":"Aneja","year":"2015","journal-title":"J. Med. Chem."},{"key":"B5","doi-asserted-by":"publisher","first-page":"859","DOI":"10.1038\/nature09420","article-title":"Non-muscle myosin IIA is a functional entry receptor for herpes simplex virus-1.","volume":"467","author":"Arii","year":"2010","journal-title":"Nature"},{"key":"B6","doi-asserted-by":"publisher","first-page":"1879","DOI":"10.1128\/JVI.03079-14","article-title":"Nonmuscle myosin heavy chain IIb mediates herpes simplex virus 1 entry.","volume":"89","author":"Arii","year":"2015","journal-title":"J. Virol."},{"key":"B7","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1007\/978-981-10-7230-7_1","article-title":"The role of HSV glycoproteins in mediating cell entry.","volume":"1045","author":"Arii","year":"2018","journal-title":"Adv. Exp. Med. Biol."},{"key":"B8","doi-asserted-by":"publisher","first-page":"12292","DOI":"10.1128\/JVI.01700-10","article-title":"Cascade of events governing cell-cell fusion induced by herpes simplex virus glycoproteins gD, gH\/gL, and gB.","volume":"84","author":"Atanasiu","year":"","journal-title":"J. Virol."},{"key":"B9","doi-asserted-by":"publisher","first-page":"10535","DOI":"10.1128\/JVI.01501-16","article-title":"Regulation of herpes simplex virus glycoprotein-induced cascade of events governing cell-cell fusion.","volume":"90","author":"Atanasiu","year":"2016","journal-title":"J. Virol."},{"key":"B10","doi-asserted-by":"publisher","first-page":"18718","DOI":"10.1073\/pnas.0707452104","article-title":"Bimolecular complementation reveals that glycoproteins gB and gH\/gL of herpes simplex virus interact with each other during cell fusion.","volume":"104","author":"Atanasiu","year":"2007","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"B11","doi-asserted-by":"publisher","first-page":"3825","DOI":"10.1128\/JVI.02687-09","article-title":"Bimolecular complementation defines functional regions of Herpes simplex virus gB that are involved with gH\/gL as a necessary step leading to cell fusion.","volume":"84","author":"Atanasiu","year":"","journal-title":"J. Virol."},{"key":"B12","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/978-3-319-53168-7_1","article-title":"Initial contact: the first steps in herpesvirus entry.","volume":"223","author":"Azab","year":"2017","journal-title":"Adv. Anat. Embryol. Cell Biol."},{"key":"B13","doi-asserted-by":"publisher","first-page":"387","DOI":"10.1146\/annurev-pathol-052016-100506","article-title":"The pathogenesis of ebola virus disease.","volume":"12","author":"Baseler","year":"2017","journal-title":"Annu. Rev. Pathol."},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.1186\/1742-4690-10-153","article-title":"Interactions of peptide triazole thiols with Env gp120 induce irreversible breakdown and inactivation of HIV-1 virions.","volume":"10","author":"Bastian","year":"2013","journal-title":"Retrovirology"},{"key":"B15","doi-asserted-by":"publisher","first-page":"1335","DOI":"10.1002\/cmdc.201100177","article-title":"Cell-free HIV-1 virucidal action by modified peptide triazole inhibitors of Env gp120.","volume":"6","author":"Bastian","year":"2011","journal-title":"ChemMedChem"},{"key":"B16","doi-asserted-by":"publisher","first-page":"504","DOI":"10.1038\/nature12060","article-title":"The global distribution and burden of dengue.","volume":"496","author":"Bhatt","year":"2013","journal-title":"Nature"},{"key":"B17","doi-asserted-by":"publisher","first-page":"1928","DOI":"10.1021\/bi035088i","article-title":"Mode of action for linear peptide inhibitors of HIV-1 gp120 interactions.","volume":"43","author":"Biorn","year":"2004","journal-title":"Biochemistry"},{"key":"B18","doi-asserted-by":"publisher","first-page":"421","DOI":"10.1128\/JVI.01985-15","article-title":"Functional characterization of glycoprotein H chimeras composed of conserved domains of the pseudorabies virus and herpes simplex virus 1 homologs.","volume":"90","author":"Bohm","year":"2016","journal-title":"J. Virol."},{"key":"B19","doi-asserted-by":"publisher","first-page":"10366","DOI":"10.1128\/JVI.01035-10","article-title":"Recombinant soluble, multimeric HA and NA exhibit distinctive types of protection against pandemic swine-origin 2009 A(H1N1) influenza virus infection in ferrets.","volume":"84","author":"Bosch","year":"2010","journal-title":"J. Virol."},{"key":"B20","doi-asserted-by":"publisher","first-page":"891","DOI":"10.1001\/jama.295.8.joc60020","article-title":"Adamantane resistance among influenza A viruses isolated early during the 2005-2006 influenza season in the United States.","volume":"295","author":"Bright","year":"2006","journal-title":"JAMA"},{"key":"B21","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1038\/371037a0","article-title":"Structure of influenza haemagglutinin at the pH of membrane fusion.","volume":"371","author":"Bullough","year":"1994","journal-title":"Nature"},{"key":"B22","doi-asserted-by":"publisher","first-page":"706","DOI":"10.1038\/nri891","article-title":"Antibodies, viruses and vaccines.","volume":"2","author":"Burton","year":"2002","journal-title":"Nat. Rev. Immunol."},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.1128\/JVI.00289-19","article-title":"Surface plasmon resonance reveals direct binding of herpes simplex virus glycoproteins gH\/gL to gD and locates a gH\/gl binding site on gD.","volume":"93","author":"Cairns","year":"2019","journal-title":"J. Virol."},{"key":"B24","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1016\/s1097-2765(01)00298-2","article-title":"Herpes simplex virus glycoprotein D bound to the human receptor HveA.","volume":"8","author":"Carfi","year":"2001","journal-title":"Mol. Cell"},{"key":"B25","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1159\/000464134","article-title":"Peptides derived from glycoproteins H and B of herpes simplex virus type 1 and herpes simplex virus type 2 are capable of blocking herpetic infection in vitro.","volume":"59","author":"Cetina-Corona","year":"2016","journal-title":"Intervirology"},{"key":"B26","doi-asserted-by":"publisher","first-page":"2305","DOI":"10.4155\/fmc.15.152","article-title":"Peptide triazole inactivators of HIV-1: how do they work and what is their potential?","volume":"7","author":"Chaiken","year":"2015","journal-title":"Future Med. Chem."},{"key":"B27","doi-asserted-by":"publisher","first-page":"681","DOI":"10.1016\/s0092-8674(00)81430-0","article-title":"HIV entry and its inhibition.","volume":"93","author":"Chan","year":"1998","journal-title":"Cell"},{"key":"B28","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1016\/j.antiviral.2018.05.005","article-title":"Innovation and trends in the development and approval of antiviral medicines: 1987-2017 and beyond.","volume":"155","author":"Chaudhuri","year":"2018","journal-title":"Antiviral Res."},{"key":"B29","doi-asserted-by":"publisher","first-page":"9395","DOI":"10.1128\/JVI.05119-11","article-title":"Engineered single human CD4 domains as potent HIV-1 inhibitors and components of vaccine immunogens.","volume":"85","author":"Chen","year":"2011","journal-title":"J. Virol."},{"key":"B30","doi-asserted-by":"publisher","first-page":"1125","DOI":"10.1128\/JVI.02566-13","article-title":"Exceptionally potent and broadly cross-reactive, bispecific multivalent HIV-1 inhibitors based on single human CD4 and antibody domains.","volume":"88","author":"Chen","year":"2014","journal-title":"J. Virol."},{"key":"B31","doi-asserted-by":"publisher","first-page":"17121","DOI":"10.1073\/pnas.0805297105","article-title":"Human domain antibodies to conserved sterically restricted regions on gp120 as exceptionally potent cross-reactive HIV-1 neutralizers.","volume":"105","author":"Chen","year":"2008","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"B32","doi-asserted-by":"publisher","DOI":"10.1371\/journal.ppat.1006766","article-title":"Herpes simplex viruses activate phospholipid scramblase to redistribute phosphatidylserines and Akt to the outer leaflet of the plasma membrane and promote viral entry.","volume":"14","author":"Cheshenko","year":"2018","journal-title":"PLoS Pathog."},{"key":"B33","doi-asserted-by":"publisher","first-page":"2584","DOI":"10.1096\/fj.12-220285","article-title":"HSV activates Akt to trigger calcium release and promote viral entry: novel candidate target for treatment and suppression.","volume":"27","author":"Cheshenko","year":"2013","journal-title":"FASEB J."},{"key":"B34","doi-asserted-by":"publisher","first-page":"1342","DOI":"10.7150\/ijms.21875","article-title":"Peptides as therapeutic agents for dengue virus.","volume":"14","author":"Chew","year":"2017","journal-title":"Int. J. Med. Sci."},{"key":"B35","doi-asserted-by":"publisher","first-page":"882","DOI":"10.1038\/nsmb.1837","article-title":"Crystal structure of the conserved herpesvirus fusion regulator complex gH-gL.","volume":"17","author":"Chowdary","year":"2010","journal-title":"Nat. Struct. Mol. Biol."},{"key":"B36","doi-asserted-by":"publisher","first-page":"7445","DOI":"10.1073\/pnas.0401883101","article-title":"The soluble ectodomain of herpes simplex virus gD contains a membrane-proximal pro-fusion domain and suffices to mediate virus entry.","volume":"101","author":"Cocchi","year":"2004","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"B37","doi-asserted-by":"publisher","first-page":"369","DOI":"10.1038\/nrmicro2548","article-title":"Fusing structure and function: a structural view of the herpesvirus entry machinery.","volume":"9","author":"Connolly","year":"2011","journal-title":"Nat. Rev. Microbiol."},{"key":"B38","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pntd.0000721","article-title":"Structural optimization and de novo design of dengue virus entry inhibitory peptides.","volume":"4","author":"Costin","year":"2010","journal-title":"PLoS Negl. Trop. Dis."},{"key":"B39","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1016\/j.ebiom.2017.04.029","article-title":"Visual and motor deficits in grown-up mice with congenital zika virus infection.","volume":"20","author":"Cui","year":"2017","journal-title":"EBioMedicine"},{"key":"B40","doi-asserted-by":"publisher","DOI":"10.12688\/f1000research.12271.1","article-title":"The immunology of Zika Virus.","volume":"7","author":"Culshaw","year":"2018","journal-title":"F1000Res."},{"key":"B41","doi-asserted-by":"publisher","first-page":"6574","DOI":"10.1073\/pnas.87.17.6574","article-title":"High concentrations of recombinant soluble CD4 are required to neutralize primary human immunodeficiency virus type 1 isolates.","volume":"87","author":"Daar","year":"1990","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"B42","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1007\/s00705-008-0278-4","article-title":"The order Herpesvirales.","volume":"154","author":"Davison","year":"2009","journal-title":"Arch. Virol."},{"key":"B43","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1016\/j.coviro.2013.11.002","article-title":"Concepts of papillomavirus entry into host cells.","volume":"4","author":"Day","year":"2014","journal-title":"Curr. Opin. Virol."},{"key":"B44","doi-asserted-by":"publisher","first-page":"3303","DOI":"10.1182\/blood-2008-02-138073","article-title":"Activation of natural regulatory T cells by IgG Fc-derived peptide \\\u201cTregitopes\\\u201c.","volume":"112","author":"De Groot","year":"2008","journal-title":"Blood"},{"key":"B45","doi-asserted-by":"publisher","first-page":"2667","DOI":"10.1056\/NEJMoa054512","article-title":"Oseltamivir resistance during treatment of influenza A (H5N1) infection.","volume":"353","author":"de Jong","year":"2005","journal-title":"N. Engl. J. Med."},{"key":"B46","doi-asserted-by":"publisher","DOI":"10.1038\/nrdp.2015.35","article-title":"HIV infection.","volume":"1","author":"Deeks","year":"2015","journal-title":"Nat. Rev. Dis. Primers"},{"key":"B47","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1038\/331082a0","article-title":"A soluble form of CD4 (T4) protein inhibits AIDS virus infection.","volume":"331","author":"Deen","year":"1988","journal-title":"Nature"},{"key":"B48","doi-asserted-by":"publisher","DOI":"10.1371\/journal.ppat.1002277","article-title":"Structure of herpes simplex virus glycoprotein D bound to the human receptor nectin-1.","volume":"7","author":"Di Giovine","year":"2011","journal-title":"PLoS Pathog."},{"key":"B49","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2018.01581","article-title":"Influenza A virus cell entry, replication, virion assembly and movement.","volume":"9","author":"Dou","year":"2018","journal-title":"Front. Immunol."},{"key":"B50","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1001\/jama.284.2.215","article-title":"Current evidence and future directions for targeting HIV entry: therapeutic and prophylactic strategies.","volume":"284","author":"D\u2019Souza","year":"2000","journal-title":"JAMA"},{"key":"B51","doi-asserted-by":"publisher","first-page":"12772","DOI":"10.1073\/pnas.0701478104","article-title":"Design of helical, oligomeric HIV-1 fusion inhibitor peptides with potent activity against enfuvirtide-resistant virus.","volume":"104","author":"Dwyer","year":"2007","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"B52","doi-asserted-by":"publisher","first-page":"1236","DOI":"10.1038\/mt.2011.30","article-title":"Secreted antiviral entry inhibitory (SAVE) peptides for gene therapy of HIV infection.","volume":"19","author":"Egerer","year":"2011","journal-title":"Mol. Ther."},{"key":"B53","doi-asserted-by":"publisher","first-page":"800","DOI":"10.3390\/v4050800","article-title":"Herpes virus fusion and entry: a story with many characters.","volume":"4","author":"Eisenberg","year":"2012","journal-title":"Viruses"},{"key":"B54","doi-asserted-by":"publisher","first-page":"246","DOI":"10.1126\/science.1171491","article-title":"Antibody recognition of a highly conserved influenza virus epitope.","volume":"324","author":"Ekiert","year":"2009","journal-title":"Science"},{"key":"B55","doi-asserted-by":"publisher","first-page":"526","DOI":"10.1038\/nature11414","article-title":"Cross-neutralization of influenza A viruses mediated by a single antibody loop.","volume":"489","author":"Ekiert","year":"2012","journal-title":"Nature"},{"key":"B56","doi-asserted-by":"publisher","first-page":"416","DOI":"10.7326\/0003-4819-76-3-112-6-416","article-title":"Herpes simplex virus resistant to acyclovir. A study in a tertiary care center.","volume":"112","author":"Englund","year":"1990","journal-title":"Ann. Intern. Med."},{"key":"B57","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1038\/gt.2013.70","article-title":"A novel gene therapy strategy using secreted multifunctional anti-HIV proteins to confer protection to gene-modified and unmodified target cells.","volume":"21","author":"Falkenhagen","year":"2014","journal-title":"Gene Ther."},{"key":"B58","doi-asserted-by":"publisher","first-page":"132","DOI":"10.1016\/j.omtn.2017.08.017","article-title":"Control of HIV infection in vivo using gene therapy with a secreted entry inhibitor.","volume":"9","author":"Falkenhagen","year":"2017","journal-title":"Mol. Ther. Nucleic Acids"},{"key":"B59","doi-asserted-by":"publisher","first-page":"1170","DOI":"10.1038\/nm1319","article-title":"Efficacy of short-term monotherapy with maraviroc, a new CCR5 antagonist, in patients infected with HIV-1.","volume":"11","author":"Fatkenheuer","year":"2005","journal-title":"Nat. Med."},{"key":"B60","doi-asserted-by":"crossref","first-page":"5795","DOI":"10.1128\/JVI.73.7.5795-5802.1999","article-title":"Peptide ligands to human immunodeficiency virus type 1 gp120 identified from phage display libraries.","volume":"73","author":"Ferrer","year":"1999","journal-title":"J. Virol."},{"key":"B61","doi-asserted-by":"publisher","first-page":"816","DOI":"10.1126\/science.1202617","article-title":"Computational design of proteins targeting the conserved stem region of influenza hemagglutinin.","volume":"332","author":"Fleishman","year":"2011","journal-title":"Science"},{"key":"B62","doi-asserted-by":"publisher","first-page":"148","DOI":"10.1002\/psc.2489","article-title":"Peptide inhibitors against herpes simplex virus infections.","volume":"19","author":"Galdiero","year":"2013","journal-title":"J. Pept. Sci."},{"key":"B63","doi-asserted-by":"publisher","first-page":"12656","DOI":"10.1128\/JVI.01727-13","article-title":"Displacement of the C terminus of herpes simplex virus gD is sufficient to expose the fusion-activating interfaces on gD.","volume":"87","author":"Gallagher","year":"2013","journal-title":"J. Virol."},{"key":"B64","doi-asserted-by":"publisher","first-page":"28403","DOI":"10.1074\/jbc.R110.129809","article-title":"Influenza hemagglutinin and neuraminidase membrane glycoproteins.","volume":"285","author":"Gamblin","year":"2010","journal-title":"J. Biol. Chem."},{"key":"B65","doi-asserted-by":"publisher","first-page":"300","DOI":"10.1093\/icb\/43.2.300","article-title":"The role of antimicrobial peptides in innate immunity.","volume":"43","author":"Ganz","year":"2003","journal-title":"Integr. Comp. Biol."},{"key":"B66","doi-asserted-by":"crossref","first-page":"3475","DOI":"10.1128\/JVI.72.4.3475-3478.1998","article-title":"CD4-immunoglobulin G2 protects Hu-PBL-SCID mice against challenge by primary human immunodeficiency virus type 1 isolates.","volume":"72","author":"Gauduin","year":"1998","journal-title":"J. Virol."},{"key":"B67","doi-asserted-by":"publisher","first-page":"230","DOI":"10.1016\/0042-6822(86)90026-7","article-title":"The properties and sequence of glycoprotein H of herpes simplex virus type 1.","volume":"153","author":"Gompels","year":"1986","journal-title":"Virology"},{"key":"B68","doi-asserted-by":"publisher","first-page":"783","DOI":"10.1038\/nri1706","article-title":"Perils at mucosal front lines for HIV and SIV and their hosts.","volume":"5","author":"Haase","year":"2005","journal-title":"Nat. Rev. Immunol."},{"key":"B69","doi-asserted-by":"publisher","DOI":"10.1371\/journal.ppat.1000360","article-title":"Soluble CD4 and CD4-mimetic compounds inhibit HIV-1 infection by induction of a short-lived activated state.","volume":"5","author":"Haim","year":"2009","journal-title":"PLoS Pathog."},{"key":"B70","doi-asserted-by":"publisher","first-page":"1644","DOI":"10.1016\/S0140-6736(07)61687-0","article-title":"Dengue.","volume":"370","author":"Halstead","year":"2007","journal-title":"Lancet"},{"key":"B71","doi-asserted-by":"publisher","first-page":"951","DOI":"10.1080\/13543784.2018.1548609","article-title":"Investigational drugs for the treatment of Zika virus infection: a preclinical and clinical update.","volume":"27","author":"Han","year":"2018","journal-title":"Expert Opin. Investig. Drugs"},{"key":"B72","doi-asserted-by":"publisher","first-page":"690","DOI":"10.1038\/nsmb.1456","article-title":"Viral membrane fusion.","volume":"15","author":"Harrison","year":"2008","journal-title":"Nat. Struct. Mol. Biol."},{"key":"B73","doi-asserted-by":"publisher","first-page":"498","DOI":"10.1016\/j.virol.2015.03.043","article-title":"Viral membrane fusion.","volume":"47","author":"Harrison","year":"2015","journal-title":"Virology"},{"key":"B74","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1126\/science.1126548","article-title":"Crystal structure of glycoprotein B from herpes simplex virus 1.","volume":"313","author":"Heldwein","year":"2006","journal-title":"Science"},{"key":"B75","doi-asserted-by":"publisher","first-page":"587","DOI":"10.1016\/j.immuni.2017.03.018","article-title":"An amphibian host defense peptide is virucidal for human H1 hemagglutinin-bearing influenza viruses.","volume":"46","author":"Holthausen","year":"2017","journal-title":"Immunity"},{"key":"B76","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1016\/j.chom.2015.02.012","article-title":"Influenza vaccines: challenges and solutions.","volume":"17","author":"Houser","year":"2015","journal-title":"Cell Host Microbe"},{"key":"B77","doi-asserted-by":"publisher","DOI":"10.1186\/1743-422X-2-49","article-title":"Peptide inhibitors of dengue virus and West Nile virus infectivity.","volume":"2","author":"Hrobowski","year":"2005","journal-title":"Virol. J."},{"key":"B78","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1016\/j.virusres.2008.07.022","article-title":"Characterization of the interaction of domain III of the envelope protein of dengue virus with putative receptors from CHO cells.","volume":"137","author":"Huerta","year":"2008","journal-title":"Virus Res."},{"key":"B79","doi-asserted-by":"publisher","first-page":"378","DOI":"10.1128\/jvi.78.1.378-388.2004","article-title":"An external loop region of domain III of dengue virus type 2 envelope protein is involved in serotype-specific binding to mosquito but not mammalian cells.","volume":"78","author":"Hung","year":"2004","journal-title":"J. Virol."},{"key":"B80","doi-asserted-by":"publisher","first-page":"423","DOI":"10.1128\/aac.48.2.423-429.2004","article-title":"Treatment of advanced human immunodeficiency virus type 1 disease with the viral entry inhibitor PRO 542.","volume":"48","author":"Jacobson","year":"2004","journal-title":"Antimicrob. Agents Chemother."},{"key":"B81","doi-asserted-by":"publisher","first-page":"326","DOI":"10.1086\/315698","article-title":"Single-dose safety, pharmacology, and antiviral activity of the human immunodeficiency virus (HIV) type 1 entry inhibitor PRO 542 in HIV-infected adults.","volume":"182","author":"Jacobson","year":"2000","journal-title":"J. Infect. Dis."},{"key":"B82","doi-asserted-by":"publisher","DOI":"10.1038\/365113a0","article-title":"HIV-1 inhibition by a peptide.","volume":"365","author":"Jiang","year":"","journal-title":"Nature"},{"key":"B83","doi-asserted-by":"publisher","first-page":"533","DOI":"10.1006\/bbrc.1993.2078","article-title":"Inhibition of HIV-1 infection by a fusion domain binding peptide from the HIV-1 envelope glycoprotein GP41.","volume":"195","author":"Jiang","year":"","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"B84","doi-asserted-by":"publisher","first-page":"254","DOI":"10.7326\/0003-4819-112-4-","article-title":"The safety and pharmacokinetics of recombinant soluble CD4 (rCD4) in subjects with the acquired immunodeficiency syndrome (AIDS) and AIDS-related complex. A phase 1 study.","volume":"112","author":"Kahn","year":"1990","journal-title":"Ann. Intern. Med."},{"key":"B85","doi-asserted-by":"crossref","DOI":"10.1017\/CBO9780511545313.065","article-title":"\u201cAntiviral therapy of HSV-1 and -2,\u201d","author":"Kimberlin","year":"2007","journal-title":"Human Herpesviruses: Biology, Therapy, and Immunoprophylaxis"},{"key":"B86","doi-asserted-by":"publisher","first-page":"2287","DOI":"10.1128\/JVI.02957-12","article-title":"Structure of a dengue virus envelope protein late-stage fusion intermediate.","volume":"87","author":"Klein","year":"2013","journal-title":"J. Virol."},{"key":"B87","doi-asserted-by":"publisher","first-page":"4144","DOI":"10.1038\/sj.emboj.7600875","article-title":"Structure of unliganded HSV gD reveals a mechanism for receptor-mediated activation of virus entry.","volume":"24","author":"Krummenacher","year":"2005","journal-title":"EMBO J."},{"key":"B88","doi-asserted-by":"publisher","first-page":"717","DOI":"10.1016\/s0092-8674(02)00660-8","article-title":"Structure of dengue virus: implications for flavivirus organization, maturation, and fusion.","volume":"108","author":"Kuhn","year":"2002","journal-title":"Cell"},{"key":"B89","doi-asserted-by":"publisher","first-page":"525","DOI":"10.1016\/j.tim.2017.09.010","article-title":"Breach: host membrane penetration and entry by nonenveloped viruses.","volume":"26","author":"Kumar","year":"2018","journal-title":"Trends Microbiol."},{"key":"B90","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1128\/JVI.72.1.73-83.1998","article-title":"Phylogeny of the genus Flavivirus.","volume":"72","author":"Kuno","year":"1998","journal-title":"J. Virol."},{"key":"B91","doi-asserted-by":"publisher","first-page":"2175","DOI":"10.1056\/NEJMoa035026","article-title":"Enfuvirtide, an HIV-1 fusion inhibitor, for drug-resistant HIV infection in North and South America.","volume":"348","author":"Lalezari","year":"2003","journal-title":"N. Engl. J. Med."},{"key":"B92","doi-asserted-by":"publisher","first-page":"1935","DOI":"10.1107\/S0907444913016776","article-title":"Structural basis for the antibody neutralization of herpes simplex virus.","author":"Lee","year":"2013","journal-title":"Acta Crystallogr. D Biol. Crystallogr."},{"key":"B93","doi-asserted-by":"publisher","first-page":"4220","DOI":"10.1016\/j.bmc.2007.03.064","article-title":"Synthesis and anti-HIV activity of trivalent CD4-mimetic miniproteins.","volume":"15","author":"Li","year":"2007","journal-title":"Bioorg. Med. Chem."},{"key":"B94","doi-asserted-by":"publisher","first-page":"783","DOI":"10.1021\/bc049960r","article-title":"Synthetic bivalent CD4-mimetic miniproteins show enhanced anti-HIV activity over the monovalent miniprotein.","volume":"15","author":"Li","year":"2004","journal-title":"Bioconjug. Chem."},{"key":"B95","doi-asserted-by":"publisher","first-page":"1830","DOI":"10.1126\/science.1153263","article-title":"The flavivirus precursor membrane-envelope protein complex: structure and maturation.","volume":"319","author":"Li","year":"2008","journal-title":"Science"},{"key":"B96","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1038\/nature07159","article-title":"Molecular architecture of native HIV-1 gp120 trimers.","volume":"455","author":"Liu","year":"2008","journal-title":"Nature"},{"key":"B97","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0050995","article-title":"Release of dengue virus genome induced by a peptide inhibitor.","volume":"7","author":"Lok","year":"2012","journal-title":"PLoS One"},{"key":"B98","doi-asserted-by":"publisher","DOI":"10.1186\/1742-4690-9-104","article-title":"A bivalent recombinant protein inactivates HIV-1 by targeting the gp41 prehairpin fusion intermediate induced by CD4 D1D2 domains.","volume":"9","author":"Lu","year":"2012","journal-title":"Retrovirology"},{"key":"B99","doi-asserted-by":"publisher","first-page":"1074","DOI":"10.2174\/1568026615666150901114527","article-title":"Development of small-molecule HIV entry inhibitors specifically targeting gp120 or gp41.","volume":"16","author":"Lu","year":"2016","journal-title":"Curr. Top. Med. Chem."},{"key":"B100","doi-asserted-by":"publisher","first-page":"4441","DOI":"10.1021\/jm1002183","article-title":"Sialic acid-mimic peptides as hemagglutinin inhibitors for anti-influenza therapy.","volume":"53","author":"Matsubara","year":"2010","journal-title":"J. Med. Chem."},{"key":"B101","doi-asserted-by":"publisher","first-page":"1106","DOI":"10.1016\/j.bmc.2016.01.039","article-title":"Heptapeptide ligands against receptor-binding sites of influenza hemagglutinin toward anti-influenza therapy.","volume":"24","author":"Matsubara","year":"2016","journal-title":"Bioorg. Med. Chem."},{"key":"B102","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1007\/s11262-007-0103-2","article-title":"Computational analysis and identification of amino acid sites in dengue E proteins relevant to development of diagnostics and vaccines.","volume":"35","author":"Mazumder","year":"2007","journal-title":"Virus Genes"},{"key":"B103","doi-asserted-by":"publisher","DOI":"10.1186\/1742-4690-5-111","article-title":"Common principles and intermediates of viral protein-mediated fusion: the HIV-1 paradigm.","volume":"5","author":"Melikyan","year":"2008","journal-title":"Retrovirology"},{"key":"B104","doi-asserted-by":"publisher","first-page":"6986","DOI":"10.1073\/pnas.0832193100","article-title":"A ligand-binding pocket in the dengue virus envelope glycoprotein.","volume":"100","author":"Modis","year":"2003","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"B105","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1146\/annurev-pathol-011110-130254","article-title":"Pathogenic mechanisms of HIV disease.","volume":"6","author":"Moir","year":"2011","journal-title":"Annu. Rev. Pathol."},{"key":"B106","doi-asserted-by":"publisher","first-page":"607","DOI":"10.1586\/14760584.2016.1123098","article-title":"T cell epitope redundancy: cross-conservation of the TCR face between pathogens and self and its implications for vaccines and autoimmunity.","volume":"15","author":"Moise","year":"2016","journal-title":"Expert Rev. Vaccines"},{"key":"B107","doi-asserted-by":"publisher","DOI":"10.1155\/2019\/6491738","article-title":"Middle east respiratory syndrome coronavirus (MERS-CoV): infection, immunological response, and vaccine development.","volume":"2019","author":"Mubarak","year":"2019","journal-title":"J. Immunol. Res."},{"key":"B108","first-page":"9","article-title":"Xofluza (Baloxavir Marboxil) for the treatment of acute uncomplicated influenza.","volume":"44","author":"Ng","year":"2019","journal-title":"P T"},{"key":"B109","doi-asserted-by":"publisher","first-page":"965","DOI":"10.1111\/tra.12408","article-title":"Herpesvirus entry into host cells mediated by endosomal low pH.","volume":"17","author":"Nicola","year":"2016","journal-title":"Traffic"},{"key":"B110","doi-asserted-by":"publisher","first-page":"7508","DOI":"10.1128\/JVI.78.14.7508-7517.2004","article-title":"Cellular and viral requirements for rapid endocytic entry of herpes simplex virus.","volume":"78","author":"Nicola","year":"2004","journal-title":"J. Virol."},{"key":"B111","doi-asserted-by":"crossref","first-page":"1461","DOI":"10.1128\/JVI.67.3.1461-1471.1993","article-title":"Two mechanisms of soluble CD4 (sCD4)-mediated inhibition of human immunodeficiency virus type 1 (HIV-1) infectivity and their relation to primary HIV-1 isolates with reduced sensitivity to sCD4.","volume":"67","author":"Orloff","year":"1993","journal-title":"J. Virol."},{"key":"B112","first-page":"1647","article-title":"Orthomyxoviridae: the viruses and their replication","author":"Palese","year":"2007","journal-title":"Fields Virology"},{"key":"B113","doi-asserted-by":"publisher","first-page":"7862","DOI":"10.1128\/JVI.00168-09","article-title":"Combinations of the first and next generations of human immunodeficiency virus (HIV) fusion inhibitors exhibit a highly potent synergistic effect against enfuvirtide- sensitive and -resistant HIV type 1 strains.","volume":"83","author":"Pan","year":"2009","journal-title":"J. Virol."},{"key":"B114","doi-asserted-by":"publisher","first-page":"148","DOI":"10.1111\/cbdd.12309","article-title":"Peptide inhibitors against dengue virus infection.","volume":"84","author":"Panya","year":"2014","journal-title":"Chem. Biol. Drug Des."},{"key":"B115","doi-asserted-by":"publisher","first-page":"1093","DOI":"10.1111\/cbdd.12576","article-title":"A peptide inhibitor derived from the conserved ectodomain region of DENV membrane (M) protein with activity against dengue virus infection.","volume":"86","author":"Panya","year":"2015","journal-title":"Chem. Biol. Drug Des."},{"key":"B116","doi-asserted-by":"publisher","first-page":"931","DOI":"10.1042\/BCJ20170662","article-title":"Restricted HIV-1 Env glycan engagement by lectin-reengineered DAVEI protein chimera is sufficient for lytic inactivation of the virus.","volume":"475","author":"Parajuli","year":"2018","journal-title":"Biochem. J."},{"key":"B117","doi-asserted-by":"publisher","first-page":"6100","DOI":"10.1021\/acs.biochem.6b00570","article-title":"Lytic inactivation of human immunodeficiency virus by dual engagement of gp120 and gp41 domains in the virus Env protein trimer.","volume":"55","author":"Parajuli","year":"2016","journal-title":"Biochemistry"},{"key":"B118","first-page":"1802","article-title":"Herpesviridae","author":"Pellet","year":"2013","journal-title":"Fields Virology"},{"key":"B119","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1016\/j.clim.2005.02.019","article-title":"Suppression of HIV-1 infection in primary CD4 T cells transduced with a self-inactivating lentiviral vector encoding a membrane expressed gp41-derived fusion inhibitor.","volume":"115","author":"Perez","year":"2005","journal-title":"Clin. Immunol."},{"key":"B120","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1016\/s0010-7824(00)00156-6","article-title":"Nonoxynol-9 causes rapid exfoliation of sheets of rectal epithelium.","volume":"62","author":"Phillips","year":"2000","journal-title":"Contraception"},{"key":"B121","doi-asserted-by":"publisher","DOI":"10.1016\/s0140-6736(88)92261-1","article-title":"In vitro inactivation of HIV-1 by contraceptive sponge containing nonoxynol-9.","volume":"1","author":"Polsky","year":"1988","journal-title":"Lancet"},{"key":"B122","doi-asserted-by":"publisher","first-page":"34547","DOI":"10.1074\/jbc.M112.357061","article-title":"Theoretical investigation on the binding specificity of sialyldisaccharides with hemagglutinins of influenza A virus by molecular dynamics simulations.","volume":"287","author":"Priyadarzini","year":"2012","journal-title":"J. Biol. Chem."},{"key":"B123","doi-asserted-by":"publisher","DOI":"10.1038\/emi.2017.46","article-title":"HIV-1 gp41-targeting fusion inhibitory peptides enhance the gp120-targeting protein-mediated inactivation of HIV-1 virions.","volume":"6","author":"Qi","year":"2017","journal-title":"Emerg. Microbes Infect."},{"key":"B124","first-page":"1823","article-title":"Herpes simplex viruses","author":"Roizman","year":"2013","journal-title":"Fields Virology"},{"key":"B125","doi-asserted-by":"publisher","first-page":"529","DOI":"10.1074\/jbc.M114.608315","article-title":"Mechanism of multivalent nanoparticle encounter with HIV-1 for potency enhancement of peptide triazole virus inactivation.","volume":"290","author":"Rosemary Bastian","year":"2015","journal-title":"J. Biol. Chem."},{"key":"B126","doi-asserted-by":"publisher","DOI":"10.1186\/1741-7007-10-99","article-title":"HIV takes double hit before entry.","volume":"10","author":"Sanders","year":"2013","journal-title":"BMC Biol."},{"key":"B127","doi-asserted-by":"publisher","DOI":"10.1093\/infdis\/jiaa061","article-title":"Detection of variants with reduced baloxavir marboxil susceptibility after treatment of children with influenza A during the 2018\/2019 influenza season.","author":"Sato","year":"2020","journal-title":"J. Infect. Dis."},{"key":"B128","doi-asserted-by":"publisher","first-page":"935","DOI":"10.1016\/j.cell.2008.01.043","article-title":"PILRalpha is a herpes simplex virus-1 entry coreceptor that associates with glycoprotein B.","volume":"132","author":"Satoh","year":"2008","journal-title":"Cell"},{"key":"B129","doi-asserted-by":"publisher","DOI":"10.1371\/journal.ppat.1000851","article-title":"Peptide inhibitors of dengue-virus entry target a late-stage fusion intermediate.","volume":"6","author":"Schmidt","year":"","journal-title":"PLoS Pathog."},{"key":"B130","doi-asserted-by":"publisher","first-page":"12549","DOI":"10.1128\/JVI.01440-10","article-title":"Peptide inhibitors of flavivirus entry derived from the E protein stem.","volume":"84","author":"Schmidt","year":"","journal-title":"J. Virol."},{"key":"B131","doi-asserted-by":"publisher","first-page":"247","DOI":"10.7326\/0003-4819-112-4-247","article-title":"Recombinant soluble CD4 therapy in patients with the acquired immunodeficiency syndrome (AIDS) and AIDS-related complex. A phase I-II escalating dosage trial.","volume":"112","author":"Schooley","year":"1990","journal-title":"Ann. Intern. Med."},{"key":"B132","doi-asserted-by":"publisher","first-page":"12276","DOI":"10.3390\/molecules171012276","article-title":"Antimicrobial peptides for therapeutic applications: a review.","volume":"17","author":"Seo","year":"2012","journal-title":"Molecules"},{"key":"B133","doi-asserted-by":"publisher","first-page":"16192","DOI":"10.1021\/bi051120s","article-title":"Protein minimization of the gp120 binding region of human CD4.","volume":"44","author":"Sharma","year":"2005","journal-title":"Biochemistry"},{"key":"B134","doi-asserted-by":"publisher","first-page":"531","DOI":"10.1146\/annurev.biochem.69.1.531","article-title":"Receptor binding and membrane fusion in virus entry: the influenza hemagglutinin.","volume":"69","author":"Skehel","year":"2000","journal-title":"Annu. Rev. Biochem."},{"key":"B135","doi-asserted-by":"publisher","first-page":"1189","DOI":"10.1038\/s41590-018-0210-3","article-title":"The immune response against flaviviruses.","volume":"19","author":"Slon Campos","year":"2018","journal-title":"Nat. Immunol."},{"key":"B136","doi-asserted-by":"publisher","first-page":"637","DOI":"10.1016\/0092-8674(86)90778-6","article-title":"Identification and characterization of conserved and variable regions in the envelope gene of HTLV-III\/LAV, the retrovirus of AIDS.","volume":"45","author":"Starcich","year":"1986","journal-title":"Cell"},{"key":"B137","doi-asserted-by":"publisher","first-page":"885","DOI":"10.1097\/QAD.0000000000001415","article-title":"A novel HIV-1 gp41 tripartite model for rational design of HIV-1 fusion inhibitors with improved antiviral activity.","volume":"31","author":"Su","year":"2017","journal-title":"AIDS"},{"key":"B138","doi-asserted-by":"publisher","first-page":"866","DOI":"10.1073\/pnas.0913351107","article-title":"Myelin-associated glycoprotein mediates membrane fusion and entry of neurotropic herpesviruses.","volume":"107","author":"Suenaga","year":"2010","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"B139","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1038\/nsmb.1566","article-title":"Structural and functional bases for broad-spectrum neutralization of avian and human influenza A viruses.","volume":"16","author":"Sui","year":"2009","journal-title":"Nat. Struct. Mol. Biol."},{"key":"B140","doi-asserted-by":"crossref","first-page":"6332","DOI":"10.1128\/JVI.72.8.6332-6338.1998","article-title":"Determinants of human immunodeficiency virus type 1 envelope glycoprotein activation by soluble CD4 and monoclonal antibodies.","volume":"72","author":"Sullivan","year":"1998","journal-title":"J. Virol."},{"key":"B141","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1007\/978-1-4614-7651-1_4","article-title":"Entry of influenza virus.","volume":"790","author":"Sun","year":"2013","journal-title":"Adv. Exp. Med. Biol."},{"key":"B142","doi-asserted-by":"publisher","DOI":"10.2807\/1560-7917.ES.2019.24.12.1900170","article-title":"Influenza A(H3N2) virus exhibiting reduced susceptibility to baloxavir due to a polymerase acidic subunit I38T substitution detected from a hospitalised child without prior baloxavir treatment, Japan, January 2019.","volume":"24","author":"Takashita","year":"2019","journal-title":"Euro Surveill."},{"key":"B143","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1248\/cpb.c17-00794","article-title":"Dengue virus and its inhibitors: a brief review.","volume":"66","author":"Tian","year":"2018","journal-title":"Chem. Pharm. Bull."},{"key":"B144","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1038\/331084a0","article-title":"Soluble CD4 molecules neutralize human immunodeficiency virus type 1.","volume":"331","author":"Traunecker","year":"1988","journal-title":"Nature"},{"key":"B145","doi-asserted-by":"crossref","first-page":"6609","DOI":"10.1128\/JVI.69.11.6609-6617.1995","article-title":"Cross-clade neutralization of primary isolates of human immunodeficiency virus type 1 by human monoclonal antibodies and tetrameric CD4-IgG.","volume":"69","author":"Trkola","year":"1995","journal-title":"J. Virol."},{"key":"B146","doi-asserted-by":"publisher","first-page":"426","DOI":"10.1038\/nrmicro3475","article-title":"Broad-spectrum antivirals against viral fusion.","volume":"13","author":"Vigant","year":"2015","journal-title":"Nat. Rev. Microbiol."},{"key":"B147","doi-asserted-by":"publisher","first-page":"13091","DOI":"10.1073\/pnas.96.23.13091","article-title":"Rational engineering of a miniprotein that reproduces the core of the CD4 site interacting with HIV-1 envelope glycoprotein.","volume":"96","author":"Vita","year":"1999","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"B148","doi-asserted-by":"publisher","first-page":"449","DOI":"10.1007\/s11684-017-0589-5","article-title":"Development of small-molecule viral inhibitors targeting various stages of the life cycle of emerging and re-emerging viruses.","volume":"11","author":"Wang","year":"2017","journal-title":"Front. Med."},{"key":"B149","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1016\/j.antiviral.2016.03.001","article-title":"Inhibition of endoplasmic reticulum glucosidases is required for in vitro and in vivo dengue antiviral activity by the iminosugar UV-4.","volume":"129","author":"Warfield","year":"2016","journal-title":"Antiviral Res."},{"key":"B150","doi-asserted-by":"publisher","first-page":"965","DOI":"10.1016\/j.addr.2009.07.001","article-title":"T cell epitope: friend or foe? Immunogenicity of biologics in context.","volume":"61","author":"Weber","year":"2009","journal-title":"Adv. Drug Deliv. Rev."},{"key":"B151","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1007\/978-3-319-53168-7_2","article-title":"Herpes simplex virus membrane fusion.","volume":"223","author":"Weed","year":"2017","journal-title":"Adv. Anat. Embryol. Cell Biol."},{"key":"B152","doi-asserted-by":"publisher","first-page":"2150","DOI":"10.1016\/j.febslet.2007.01.093","article-title":"Virus membrane fusion.","volume":"581","author":"Weissenhorn","year":"2007","journal-title":"FEBS Lett."},{"key":"B153","doi-asserted-by":"publisher","first-page":"14216","DOI":"10.1073\/pnas.1111497108","article-title":"Broadly neutralizing human antibody that recognizes the receptor-binding pocket of influenza virus hemagglutinin.","volume":"108","author":"Whittle","year":"2011","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"B154","doi-asserted-by":"publisher","first-page":"9770","DOI":"10.1073\/pnas.91.21.9770","article-title":"Peptides corresponding to a predictive alpha-helical domain of human immunodeficiency virus type 1 gp41 are potent inhibitors of virus infection.","volume":"91","author":"Wild","year":"1994","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"B155","doi-asserted-by":"publisher","first-page":"1101","DOI":"10.1038\/nm.4184","article-title":"Identification of small-molecule inhibitors of Zika virus infection and induced neural cell death via a drug repurposing screen.","volume":"22","author":"Xu","year":"2016","journal-title":"Nat. Med."},{"key":"B156","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1097\/QAI.0000000000000265","article-title":"Synergistic effect resulting from combinations of a bifunctional HIV-1 antagonist with antiretroviral drugs.","volume":"67","author":"Xu","year":"2014","journal-title":"J. Acquir. Immune Defic. Syndr."},{"key":"B157","doi-asserted-by":"publisher","DOI":"10.3389\/fmicb.2019.02031","article-title":"Soluble recombinant hemagglutinin protein of H1N1pdm09 influenza virus elicits cross-protection against a lethal H5N1 challenge in mice.","volume":"10","author":"Yamada","year":"2019","journal-title":"Front. Microbiol."},{"key":"B158","doi-asserted-by":"publisher","first-page":"352","DOI":"10.3390\/v5010352","article-title":"Influenza A virus entry inhibitors targeting the hemagglutinin.","volume":"5","author":"Yang","year":"2013","journal-title":"Viruses"},{"key":"B159","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms15672","article-title":"A peptide-based viral inactivator inhibits Zika virus infection in pregnant mice and fetuses.","volume":"8","author":"Yu","year":"2017","journal-title":"Nat. Commun."},{"key":"B160","doi-asserted-by":"publisher","first-page":"176","DOI":"10.1016\/j.jconrel.2019.02.016","article-title":"Current strategies in extending half-lives of therapeutic proteins.","volume":"301","author":"Zaman","year":"2019","journal-title":"J. Control. Release"},{"key":"B161","doi-asserted-by":"publisher","first-page":"4176","DOI":"10.1073\/pnas.1523234113","article-title":"Two distinct trimeric conformations of natively membrane-anchored full-length herpes simplex virus 1 glycoprotein B.","volume":"113","author":"Zeev-Ben-Mordehai","year":"2016","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"B162","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1080\/13543784.2017.1269170","article-title":"Investigational hemagglutinin-targeted influenza virus inhibitors.","volume":"26","author":"Zeng","year":"2017","journal-title":"Expert Opin. Investig. Drugs"},{"key":"B163","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1038\/nsmb.2463","article-title":"Cryo-EM structure of the mature dengue virus at 3.5-A resolution.","volume":"20","author":"Zhang","year":"2013","journal-title":"Nat. Struct. Mol. Biol."}],"container-title":["Frontiers in Microbiology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fmicb.2020.01063\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,5,25]],"date-time":"2020-05-25T00:49:13Z","timestamp":1590367753000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fmicb.2020.01063\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,5,25]]},"references-count":163,"alternative-id":["10.3389\/fmicb.2020.01063"],"URL":"https:\/\/doi.org\/10.3389\/fmicb.2020.01063","relation":{},"ISSN":["1664-302X"],"issn-type":[{"value":"1664-302X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,5,25]]},"article-number":"1063"}}